Global Bioprosthetics Market Growth (Status and Outlook) 2023-2029
Bioprosthetics are the material obtained from human or other species for medical implantations. Bioprostheses has shown significant advances from past few years, as their basic characteristic, they become degraded until their complete elimination in the host body. Bioprosthesis will gradually degrade in the recipient will determine the formation of a neotissue in its place, which will completely replace the biomaterial in the long term. Ideally , the bioprosthetics are to achieve not only the repair of the damaged zone but also the regeneration of an adequately organized tissue that will promote angiogenesis and even recruit growth factors acquiring characteristics similar to those of healthy tissue.
LPI (LP Information)' newest research report, the “Bioprosthetics Industry Forecast” looks at past sales and reviews total world Bioprosthetics sales in 2022, providing a comprehensive analysis by region and market sector of projected Bioprosthetics sales for 2023 through 2029. With Bioprosthetics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bioprosthetics industry.
This Insight Report provides a comprehensive analysis of the global Bioprosthetics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bioprosthetics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bioprosthetics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bioprosthetics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bioprosthetics.
The global Bioprosthetics market size is projected to grow from US$ 2972.7 million in 2022 to US$ 4522.1 million in 2029; it is expected to grow at a CAGR of 6.2% from 2023 to 2029.
In 2017, Europe captured a sizeable share of the regional bioprosthetics vertical with a share of near 40.0%. The presence of clearly-defined reimbursement models, prominent industry players, and the large patient volume present in this region are responsible for the large share. Moreover, the formulated, stringent regulatory policies increasingly ensuring patient safety and maintaining high treatment efficacy standards are anticipated to drive the demand for these devices in this region.
This report presents a comprehensive overview, market shares, and growth opportunities of Bioprosthetics market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Allograft
Xenograft
Segmentation by application
Cardiovascular
Plastic Surgery
Wound Healing
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
LeMaitre Vascular, Inc.
Braile Biomedica, Inc.
Labcor Laboratorios Ltd.
Maquet Metinge Group
Medtronic Plc.
Aortech International Plc.
CryoLife, Inc.
Sorin Group
Humacyte, Inc.
Ethicon, Inc.
Life Cell Corporation
Organogenesis, Inc.
Abbott
Edwards Lifesciences Corporation
JenaValve Technology GmbH
Please note: The report will take approximately 2 business days to prepare and deliver.